Skip to content

Clinical trials

Phase 3 Hepatitis C trials in Egypt

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: Egypt Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20123
20131
20141
20151
20161
20171
20182
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status5
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Egyptian Liver Hospital2
Gilead Sciences2
Ain Shams University1
Atea Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Cairo University1
Dr. Nadia AbdelAaty AbdelKader1
Egyptian Military Medical Services1
French National Agency for Research on AIDS and Viral Hepatitis1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C14
Hepatitis C, Chronic6
Liver Diseases2
Virus Diseases2
Digestive System Diseases1
Enterovirus Infections1
Flaviviridae Infections1
Hepatitis1
Hepatitis, Chronic1
Hepatitis, Viral, Human1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.